Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
World J Gastroenterol. 2012 Dec 28;18(48):7271-8. doi: 10.3748/wjg.v18.i48.7271.
To investigate the impact of intestinal ischemia/reperfusion (I/R) injury and lymph drainage on distant organs in rats.
Thirty-two Sprague-Dawley male rats, weighing 280-320 g, were randomly divided into blank, sham, I/R, and ischemia/reperfusion and drainage (I/R + D) groups (n = 8). All rats were subjected to 60 min ischemia by clamping the superior mesenteric artery, followed by 120 min reperfusion. The rats in the I/R + D group received intestinal lymph drainage for 180 min. In the sham group, the abdominal cavity was opened for 180 min, but the rats received no treatment. The blank group served as a normal and untreated control. A chromogenic limulus assay kit was used for quantitative detection of serum endotoxin. The serum concentrations of tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-1β, soluble cell adhesion molecules (sICAM-1), and high mobility group protein box 1 (HMGB1) were determined with an enzyme-linked immunosorbent assay kit. Histological evaluations of the intestine, liver, kidney, and lung were performed by hematoxylin and eosin staining and immunohistochemistry. HMGB1 protein expression was assayed by western blot analysis.
The serum levels of endotoxin and HMGB1 in the I/R and I/R + D groups were significantly higher than those in the sham group (endotoxin, I/R and I/R + D vs sham: 0.033 ± 0.004 EU/mL, 0.024 ± 0.003 EU/mL vs 0.017 ± 0.009 EU/mL, respectively, P < 0.05; HMGB1, I/R and I/R + D vs sham: 5.473 ± 0.963 EU/mL, 4.906 ± 0.552 EU/mL vs 0.476 ± 0.406 EU/mL, respectively, P < 0.05). In addition, endotoxin and HMGB1 were significantly lower in the I/R + D group compared to the I/R group (P < 0.05). The serum inflammatory factors IL-6, IL-1β, and sICAM-1 in the I/R and I/R + D groups were significantly higher than those in the sham group (IL-6, I/R and I/R + D vs sham: 41.773 ± 9.753 pg/mL, 19.204 ± 4.136 pg/mL vs 11.566 ± 2.973 pg/mL, respectively, P < 0.05; IL-1β, I/R and I/R + D vs sham: 144.646 ± 29.378 pg/mL, 65.829 ± 10.888 pg/mL vs 38.178 ± 7.157 pg/mL, respectively, P < 0.05; sICAM-1, I/R and I/R + D vs sham: 97.360 ± 12.714 ng/mL, 48.401 ± 6.547 ng/mL vs 33.073 ± 5.957 ng/mL, respectively; P < 0.05). The serum TNF-α in the I/R group were significantly higher than in the sham group (45.863 ± 11.553 pg/mL vs 18.863 ± 6.679 pg/mL, respectively, P < 0.05). These factors were significantly lower in the I/R + D group compared to the I/R group (P < 0.05). The HMGB1 immunohistochemical staining results showed no staining or apparent injury in the blank group, and slight staining at the top of the microvillus was detected in the sham group. In the I/R group, both the top of villi and the basement membrane were stained for HMGB1 in most areas, and injury in the I/R + D group was less than that in the I/R group. HMGB1 expression in the liver, kidney, and lung of rats in the I/R + D group was significantly lower than the rats in the I/R group (P < 0.05).
Lymph drainage could block the "gut-lymph" pathway, improve intestinal barrier function, and attenuate distant organ injury incurred by intestinal I/R.
研究肠缺血/再灌注(I/R)损伤和淋巴引流对大鼠远隔器官的影响。
32 只雄性 Sprague-Dawley 大鼠,体重 280-320 g,随机分为空白组、假手术组、I/R 组和缺血/再灌注和引流(I/R + D)组(n = 8)。所有大鼠均通过夹闭肠系膜上动脉 60 min 造成 I/R,然后再灌注 120 min。I/R + D 组进行肠淋巴引流 180 min。在假手术组中,打开腹腔 180 min,但不进行任何治疗。空白组作为正常且未经处理的对照。采用显色鲎试验试剂盒定量检测血清内毒素。采用酶联免疫吸附试验试剂盒检测血清肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-6、IL-1β、可溶性细胞间黏附分子(sICAM-1)和高迁移率族蛋白框 1(HMGB1)的浓度。通过苏木精和伊红染色和免疫组织化学评估肠、肝、肾和肺的组织学变化。采用 Western blot 分析检测 HMGB1 蛋白表达。
I/R 和 I/R + D 组的血清内毒素和 HMGB1 水平明显高于假手术组(内毒素:I/R 和 I/R + D 组与假手术组相比:0.033 ± 0.004 EU/mL,0.024 ± 0.003 EU/mL 比 0.017 ± 0.009 EU/mL,P < 0.05;HMGB1:I/R 和 I/R + D 组与假手术组相比:5.473 ± 0.963 EU/mL,4.906 ± 0.552 EU/mL 比 0.476 ± 0.406 EU/mL,P < 0.05)。此外,与 I/R 组相比,I/R + D 组的内毒素和 HMGB1 明显降低(P < 0.05)。I/R 和 I/R + D 组的血清炎症因子 IL-6、IL-1β和 sICAM-1 明显高于假手术组(IL-6:I/R 和 I/R + D 组与假手术组相比:41.773 ± 9.753 pg/mL,19.204 ± 4.136 pg/mL 比 11.566 ± 2.973 pg/mL,P < 0.05;IL-1β:I/R 和 I/R + D 组与假手术组相比:144.646 ± 29.378 pg/mL,65.829 ± 10.888 pg/mL 比 38.178 ± 7.157 pg/mL,P < 0.05;sICAM-1:I/R 和 I/R + D 组与假手术组相比:97.360 ± 12.714 ng/mL,48.401 ± 6.547 ng/mL 比 33.073 ± 5.957 ng/mL,P < 0.05)。I/R 组的血清 TNF-α明显高于假手术组(45.863 ± 11.553 pg/mL 比 18.863 ± 6.679 pg/mL,P < 0.05)。与 I/R 组相比,I/R + D 组的这些因子明显降低(P < 0.05)。HMGB1 免疫组化染色结果显示空白组无染色或明显损伤,假手术组微绒毛顶端有轻微染色。在 I/R 组中,大多数区域的绒毛顶端和基膜均对 HMGB1 进行了染色,而 I/R + D 组的损伤程度低于 I/R 组。I/R + D 组大鼠肝、肾和肺组织的 HMGB1 表达明显低于 I/R 组(P < 0.05)。
淋巴引流可阻断“肠-淋巴”途径,改善肠道屏障功能,减轻肠 I/R 引起的远隔器官损伤。